A Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- (9CI) DMF (Drug Master File) is a document detailing the whole manufacturing process of Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- (9CI) active pharmaceutical ingredient (API) in detail. Different forms of Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- (9CI) DMFs exist exist since differing nations have different regulations, such as Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- (9CI) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- (9CI) DMF submitted to regulatory agencies in the US is known as a USDMF. Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- (9CI) USDMF includes data on Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- (9CI)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- (9CI) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- (9CI) suppliers with USDMF on PharmaCompass.